Fortis Healthcare’s Post

📢All 12 manuscripts in the #SpecialIssue “#Hematologic #Malignancies: Challenges from Diagnosis to Treatment”, led by Dr. Ioanna Sakellari and Dr. Eleni Gavriilaki, Hematology Department and Dr. Eleni Gavriilaki, have been published! 🎉🎉 📌You are welcome to read via the following link: https://lnkd.in/dyADYnGy

At #ASH24, Hammad Tashkandi, MD discussed the clinical relevance in classification methods and the prognostic implications of subgrouping within TP53-mutated myelodysplastic neoplasms as outlined by WHO and ICC. Read more: https://lnkd.in/e_SzcJXH American Society of Hematology #MoffittASH24

New publication 📝 Retrospective analysis published in Hematology provides new insights for #AcuteLymphoblasticLeukemia, see: https://loom.ly/vnLhcDM #ALLsm #leusm #MedEducation

#Congress | 🔎 What subjects were amplified by #HCPs through social media during #EHA2024? In June, took place the European Hematology Association (EHA) 2024 Hybrid Congress. The following pages provide a brief overview of the volume of conversations, the share of voice of clinical trials most discussed, or top hashtags. Moreover, discover a focus on #multiplemyeloma with the topics of discussions. Access the SML EHA2024 full report by clicking this link 👉 https://lnkd.in/e6-MYzHj

“Thrilled to attend the Brazilian Congress of Hematology, Hemotherapy, and Cellular Therapy (HEMO)! An incredible opportunity to connect with leading experts and explore advancements shaping the future of hematology. The integration of science and clinical practice continues to strengthen our commitment to research and innovation to improve patients’ lives. #HEMO2024 #MedicalScienceLiaison #HealthcareInnovation #ClinicalResearch”

Especially lessons about clinical suspicion and complete blood cell abnormalities should be taught #bloodcancerawereness

During #ASH24, Wael Gamal, PhD discusses identifying the role of endoplasmic reticulum stress in CLL T-cell dysfunction. Read more: https://lnkd.in/eJsXp-td American Society of Hematology #MoffittASH24

📰Published in Seminars in Hematology Review summarizes current evidence of novel antigens & their clinical potential. Together with current CAR T-cell therapy & T-cell engagers, these approaches might lead to the next frontier   READ➡️https://lnkd.in/eMBz4c-D  #MultipleMyeloma

How can your laboratory help reduce unnecessary complications for newly diagnosed Multiple Myeloma patients? Find out how from Prof. Guy Pratt who discusses how your laboratory can help guide blood test requesting and appropriate hematology referral. Download our case studies from hospitals in the United Kingdom, United States and Spain by here: https://hubs.li/Q02phTNn0

IACH News of the week 20/October • 2024. Here is this week’s newsletter. A brief, up-to-date summary of the last week in hematology. https://lnkd.in/dSz-KtSy International Academy for Clinical Hematology (IACH) Mohamad Mohty CME Congresses Controversies in Multiple Myeloma (COMy)